Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atrovent 20micrograms/dose inhaler CFC free
0301020I0BBAJAN
|
Atrovent | Ipratropium bromide | Respiratory System | 10,281 |
|
Atrovent 500micrograms/2ml nebuliser liquid UDVs
0301020I0BBACAC
|
Atrovent | Ipratropium bromide | Respiratory System | 1,288 |
|
Atrovent 250micrograms/1ml nebuliser liquid UDVs
0301020I0BBAFAF
|
Atrovent | Ipratropium bromide | Respiratory System | 992 |
|
Atrovent 20micrograms/dose Autohaler
0301020I0BBAGAG
|
Atrovent | Ipratropium bromide | Respiratory System | No data available |
|
Atrovent 20micrograms/dose inhaler
0301020I0BBAAAA
|
Atrovent | Ipratropium bromide | Respiratory System | No data available |
|
Atrovent 40microgram Aerocaps
0301020I0BBAIAI
|
Atrovent | Ipratropium bromide | Respiratory System | No data available |
|
Atrovent 40microgram Aerocaps with Aerohaler
0301020I0BBAHAH
|
Atrovent | Ipratropium bromide | Respiratory System | No data available |
|
Atrovent Forte 40micrograms/dose inhaler
0301020I0BBADAD
|
Atrovent | Ipratropium bromide | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.